Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access April 9, 2010

Aorta transplantation in young apolipoprotein E-deficient mice: Possible model for studies on regression of atherosclerotic lesions?

  • Zbyněk Tonar EMAIL logo , Dagmar Bobková , Kirsti Witter , Vít Matějka , Jana Havlíčková , Věra Lánská and Rudolf Poledne
From the journal Open Medicine


Syngeneic transplantation of murine aorta segments with advanced atherosclerotic lesions in defined recipients is a valuable model for regression studies. To date, this model has not been used to study the regression of initial atherosclerotic lesions. The aim of this study was to evaluate a microsurgical technique of syngeneic heterotopic transplantation of the thoracic aorta of young apolipoprotein E-deficient (ApoE-/-) mice to the abdominal aorta of wild-type recipients. Stereological quantification methods were tested in order to assess changes in structure and volume of the aortic wall including the involvement of immune cells in changes of the atherosclerotic lesions. The animals were euthanised one month after surgery and histological analysis including stereological quantification of changes in both the grafts and adjacent aorta segments was performed. The overall survival rate of the recipients was 62.5%. No regression of initial atherosclerotic lesion was achieved and neointima formation and elastin degradation prevailed in all transplanted specimens. The volume of the arteriosclerotic lesions was higher (p<0.001) and elastin length density was lower (p<0.001) in transplanted ApoE-/- samples as compared to adjacent segments. In transplanted grafts, T- and B-lymphocytes, macrophages and neutrophilic granulocytes formed non-random clusters within the vessel wall and they were colocalised with the sutures. The reproducibility of the promising regression model was derogated in young mice by the striking dependence of the results upon the operation technique. Stereological assessment has proven to be accurate, correct and reproducible; it has provided us with robust quantitative estimates, which can be achieved with a reasonable effort.

[1] Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M., Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E- deficient mice created by homologous recombination in ES cells. Cell, 1992, 71,343–353 in Google Scholar

[2] Breslow J.L. Transgenic mouse model of lipoprotein metabolism and atherosclerosis. PNAS, 1993, 90, 8314–8318 in Google Scholar

[3] Breslow J.L. Mouse models of atherosclerosis. Science 1996, 272, 685–688 in Google Scholar

[4] von Eckardstein A. Cholesterol efflux from macrophages and other cells. Curr. Opin. Lipidol., 1996, 7, 308–319 in Google Scholar

[5] Curtiss L.K. ApoE in atherosclerosis: A protein with multiple hats. Arterioscler. Thromb. Vasc. Biol., 2000, 20, 1852–1853 10.1161/01.ATV.20.8.1852Search in Google Scholar

[6] Greenow K., Pearce N.J., Ramji D.P. The key role of apolipoprotein E in atherosclerosis. J. Mol. Med., 2005, 83, 329–342. in Google Scholar

[7] van Ree J.H., van den Broek W.J., Dahlmans V.E., Groot P.H., Vidgeon-Hart M., Frants R.R., Wieringa B., Havekes L.M., Hofker M.H. Dietinduced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis, 1994, 111, 25–37 in Google Scholar

[8] Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. Vasc. Biol., 1994, 14, 133–140 10.1161/01.ATV.14.1.133Search in Google Scholar

[9] Jawien J., Nastalek P., Korbut R. Mouse models of experimental atherosclerosis. J. Physiol. Pharmacol., 2004, 55, 503–517 Search in Google Scholar

[10] Ohashi R., Mu H., Yao Q., Chen C. Cellular and molecular mechanisms of atherosclerosis with mouse models. Trends Cardiovasc. Med., 2004, 14, 187–190 in Google Scholar

[11] Garber D.W., Kulkarni K.R., Anantharamaiah G.M. A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples. J. Lip. Res., 2000, 41, 1020–1026 10.1016/S0022-2275(20)32045-9Search in Google Scholar

[12] Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest., 1955, 34, 1345–1353 in Google Scholar

[13] Gotto A.M. Jr., Pownall H.J., Havel R.J. Introduction to the Plasma Lipoproteins. In: Segrest J.P., Albers J.J. (Eds.), Methods in Enzymology, Vol. 128. Plasma Lipoproteins. Part A. Preparation, Structure, and Molecular Biology Academic Press, Orlando, 1986 10.1016/0076-6879(86)28061-1Search in Google Scholar

[14] Shi W., Wang X,, Wang N.J., McBride W.H., Lusis A.J. Effect of macrophage-derived apolipoprotein E on established atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol., 2000, 20, 2261–2266 10.1161/01.ATV.20.10.2261Search in Google Scholar

[15] van Eck M., Herijgers N., van Dijk K.W., Havekes L.M., Hofker M.H., Groot P.H., van Berkel T.J. Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2, (Arg158->Cys) on cholesterol levels and atherosclerosis in ApoEdeficient mice. Arterioscler. Thromb. Vasc. Biol., 2000, 20, 119–127 10.1161/01.ATV.20.1.119Search in Google Scholar

[16] Gough P.J., Raines E.W. Gene therapy of apolipoprotein E-deficient mice using a novel macrophage-specific retroviral vector. Blood, 2003, 101, 485–491 in Google Scholar

[17] Su Y.R., Ishiguro H., Major A.S., Dove D.E., Zhang W., Hasty A.H., Babaev V.R., Linton M.F., Fazio S. Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters. Mol. Ther., 2003, 8, 576–583 in Google Scholar

[18] Reis E.D., Li J., Fayad Z.A., Rong J.X., Hansoty D., Aguinaldo J.G., Fallon J.T., Fisher E.A. Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J. Vasc. Surg., 2001, 34, 541–547 in Google Scholar

[19] Rong J.X., Li J., Reis E.D., Choudhury R.P., Dansky H.M., Elmalem V.I., Fallon J.T., Breslow J.L., Fisher E.A. Elevating high-density lipoprotein cholesterol in apolipoprotein E — deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation, 2001, 104, 2447–2452 in Google Scholar

[20] Chereshnev I., Trogan E., Omerhodzic S., Itskovich V., Aguinaldo J.G., Fayad Z.A., Fisher E.A., Reis E.D. Mouse model of heterotopic aortic arch transplantation. J. Surg. Res., 2003, 111, 171–176 in Google Scholar

[21] Trogan E., Fayad Z.A., Itskovich V.V., Aguinaldo J.G., Mani V., Fallon J.T., Chereshnev I., Fisher E.A. Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia. Arterioscler. Thromb. Vasc. Biol., 2004, 24, 1714–1719 in Google Scholar PubMed

[22] Hansson G.K. Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2001, 21, 1876–1890 in Google Scholar

[23] Libby P. Inflammation in atherosclerosis. Nature, 2002, 420, 868–874 in Google Scholar

[24] Boyle J.J. Macrophage activation in atherosclerosis: Pathogenesis and pharmacology of plaque rupture. Curr. Vasc. Pharmacol., 2005, 3, 63–68 in Google Scholar

[25] Moos M.P.W., John N., Gräbner R., Nossmann S., Gunther B., Vollandt R., Funk C.D., Kaiser B., Habenicht A.J. The lamina adventitia is the major site of immune cell accumulation in standard chowfed apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 2386–2391 in Google Scholar

[26] Tonar Z., Bobkova D., Havlickova J., Poledne R. Vessel transplantation of apolipoprotein E-deficient mice as a model of atherosclerosis regression. Atherosclerosis Suppl., 2005, 6, 45–45 in Google Scholar

[27] European Communities. European convention for the protection of vertebrate animals used for experimental and other scientific purposes. 1986, European Treaty Series No. 123, Strasbourg Search in Google Scholar

[28] Koulack J., McAlister V.C., Giacomantonio C.A., Bitter-Suermann H, MacDonald A.S., Lee T.D. Development of a mouse aortic transplant model of chronic rejection. Microsurgery, 1995, 16, 110–113 in Google Scholar PubMed

[29] Kocova J. Overall staining of connective tissue and the muscular layer of vessels. Fol. Morphol., 1970, 3, 293–295 Search in Google Scholar

[30] Stary H.C. Natural History and Histological Classification of Atherosclerotic Lesions. An Update. Arterioscler. Thromb. Vasc. Biol., 2000, 20,, 1177–1178 10.1161/01.ATV.20.5.1177Search in Google Scholar PubMed

[31] Nachtigal P., Semecky V., Kopecky M., Gojova A., Solichova D., Zdansky P., Zadak Z. Application of stereological methods for the quantification of VCAM-1and ICAM-1 expression in early stages of rabbit atherosclerosis. Pathol. Res. Pract., 2004, 200, 219–229 in Google Scholar PubMed

[32] Howard C.V., Reed M.G. Unbiased Stereology: Three Dimensional Measurement in Microscopy. 1st edn. Royal Microscopical Society and Springer-Verlag, New York, 1998. Search in Google Scholar

[33] Russ J.C., Dehoff R.T. Classical stereological measures. In: Russ J.C., Dehoff R.T. (Eds). Practical Stereology. 2nd edn. Plenum Press, New York, 2001 10.1007/978-1-4615-1233-2Search in Google Scholar

[34] Gundersen H.J.G., Jensen E.B. The efficiency of systematic sampling in stereology and its prediction. J. Microsc., 1987, 147, 229–263 10.1111/j.1365-2818.1987.tb02837.xSearch in Google Scholar PubMed

[35] Stoyan D., Kendall W.S., Mecke J. Fibre and surface processes. In: Stoyan, D, Kendall, WS, Mecke, J (Eds). Stochastic geometry and its applications. 2nd edn. John Wiley & Sons, Chichester, 1996 Search in Google Scholar

[36] Philimonenko A.A., Janacek J., Hozak P. Statistical evaluation of colocalisation patterns in immunogold labelling experiments. J. Struct. Biol., 2000, 132, 201–210 in Google Scholar

[37] Shrout P.E., Fleiss J.L. Intraclass Correlations: Uses in Assessing Rater Reliability. Psych. Bull., 1979, 2, 420–428 in Google Scholar

[38] Lee P.C., Wang Z.L., Qian S., Watkins S.C., Lizonova A., Kovesdi I., Tzeng E., Simmons R.L., Billiar T.R., Shears L.L. Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis. Transplantation, 2000, 69, 1186–1192 in Google Scholar

[39] Soleimani B., Shi V.C. Experimental models of graft arteriosclerosis. Methods Mol. Biol., 2006, 333, 401–424 10.1385/1-59745-049-9:401Search in Google Scholar

[40] Calfa M., Aitouche A., Vazquez-Padron R.I., Gay-Rabinstein C., Lasko D., Badell J., Farji A., El-Haddad A., Liotta C., Louis L.B., Simmonds A., Pestana I.A., Pang M., Li S., Pham S.M. Aging and transplant arteriosclerosis in absence of alloreactivity and immunosuppressive drugs in a rat aortic model: recipient age’s contribution. Transplantation, 2005, 79, 1683–1690 in Google Scholar

[41] Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H., Wang T., Gregg D., Ramaswami P., Pippen A.M., Annex B.H., Dong C., Taylor D.A. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation, 2003, 29, 457–463 in Google Scholar

[42] Chow L.H., Huh S., Jiang J., Zhong R., Pickering J.G. Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection. Circulation, 1996, 94, 3079–3082 10.1161/01.CIR.94.12.3079Search in Google Scholar

[43] Sun H., Valdivia L.A., Subbotin V. Improved surgical technique for the establishment of a murine model of aortic transplantation. Microsurgery, 1998, 18, 368–371<368::AID-MICR5>3.0.CO;2-F10.1002/(SICI)1098-2752(1998)18:6<368::AID-MICR5>3.0.CO;2-FSearch in Google Scholar

[44] Hu Y., Davison F., Zhang Z., Xu Q. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation, 2003, 108, 3122–3127 in Google Scholar

[45] Sakihama H., Masunaga T., Yamashita K., Hashimoto T., Inobe M., Todo S., Uede T. Stromal cell-derived factor-1 and CXCR4 interaction is critical for development of transplant arteriosclerosis. Circulation, 2004, 110, 2924–2930 in Google Scholar

[46] Gough P.J., Gomez I.G., Wille P.T., Raines E.W. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. Journal Clin. Invest., 2006, 116, 59–69 in Google Scholar PubMed PubMed Central

[47] Ensminger S.M., Spriewald B.M., Witzke O., Morrison K., Pajaro O.E., Morris P.J., Rose M.L., Wood K.J. Kinetics of transplant arteriosclerosis in MHC-class I mismatched and fully allogeneic mouse aortic allografts, Transplantation, 2002, 73, 1068–1074 in Google Scholar PubMed

Published Online: 2010-4-9
Published in Print: 2010-6-1

© 2010 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 28.2.2024 from
Scroll to top button